Showing 7011-7020 of 19322 results for "".
Another COVID-19 Vaccine Milestone Reached
https://reachmd.com/programs/the-drug-report/another-covid-19-vaccine-milestone-reached/12119/A second COVID-19 vaccination EUA approval marks another milestone in the global battle against the COVID-19 pandemic.Living with Psoriatic Arthritis: A Doctor-Patient Conversation
https://reachmd.com/programs/medical-industry-feature/psoriatic-arthritis-doctor-patient-conversation/32265/Meet Dawn, a patient who has been living with psoriatic arthritis for some time. After experiencing diffuse joint pain, crushing fatigue, and random rashes, she found that the treatment option BIMZELX® (bimekizumab-bkzx) made a big difference for her. Tune in to hear a conversation with Dr. ElizabetThe Overlooked Valve: Why Women With Aortic Stenosis Fall Through the Cracks
https://reachmd.com/clinical-practice/cardiology/the-overlooked-valve-why-women-with-aortic-stenosis-fall-through-the-cracks/39668/Explore sex-specific disparities in the diagnosis and treatment of symptomatic severe aortic stenosis. How could your clinical bias affect outcomes in women?DESTINY-Breast11: Clinically Relevant Adverse Events
https://reachmd.com/clinical-practice/oncology-hematology/destiny-breast11-clinically-relevant-adverse-events/48988/Tune in to explore the clinically relevant safety profile of T-DXd–based neoadjuvant therapy in high-risk HER2+ early breast cancer from DESTINY-Breast11.Harnessing the NAFLD/NASH Epidemic: Preparing for a New Treatment Paradigm
https://reachmd.com/programs/cme/harnessing-the-nafldnash-epidemic-preparing-for-a-new-treatment-paradigm/15673/Do you understand your role in determining which patient may benefit the most from NASH therapy?Trial in Progress: Phase 3 MoonRISe-3 Study
https://reachmd.com/clinical-practice/oncology-hematology/trial-in-progress-phase-3-moonrise-3-study/33214/Dr. Neal Shore discusses the study design of the phase 3 MoonRISe-3 trial of TAR-210 in BCG-treated high-risk NMIBC with susceptible FGFR alterations.Can We Rely on Warm Weather to Stop the Spread of COVID-19?
https://reachmd.com/programs/covid-19-frontlines/can-we-rely-on-warm-weather-to-stop-the-spread-of-covid-19/11627/Conventional wisdom tells us that warm weather will slow the spread of contagion. But based on a recent report, that may not be the case with COVID-19.Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
https://reachmd.com/programs/cme/cracking-the-case-a-clinical-consult-on-potassium-binders-in-patients-with-chronic-kidney-disease-and-heart-failure/26748/Explore evidence for potassium binders in the challenging treatment landscape for hyperkalemia in patients with CKD.Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs
https://reachmd.com/programs/cme/shifting-treatment-paradigm-in-hfmrefhfpef-steroidal-and-nonsteroidal-mras/29908/Listen in as Drs. McMurray and Zannad explore steroidal vs. nonsteroidal MRAs—RALES, TOPCAT, FINEARTS-HF—and what it means for HFmrEF/HFpEF care.The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Patients?
https://reachmd.com/clinical-practice/obgyn-and-womens-health/the-hpv-data-is-in-what-do-the-newest-updates-in-screening-mean-for-your-patients/10075/This previously-aired broadcast provides a brief overview of the newest HPV screening recommendations and answers the audience’s pressing questions.